GB0709162D0 - Dosage foam - Google Patents
Dosage foamInfo
- Publication number
- GB0709162D0 GB0709162D0 GBGB0709162.2A GB0709162A GB0709162D0 GB 0709162 D0 GB0709162 D0 GB 0709162D0 GB 0709162 A GB0709162 A GB 0709162A GB 0709162 D0 GB0709162 D0 GB 0709162D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- dosage foam
- dosage
- foam
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Addiction (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Confectionery (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0709162.2A GB0709162D0 (en) | 2007-05-11 | 2007-05-11 | Dosage foam |
EP08758453A EP2155218A1 (en) | 2007-05-11 | 2008-05-09 | Probiotic bacteria containing oral dosage form |
PCT/EP2008/003777 WO2008138571A1 (en) | 2007-05-11 | 2008-05-09 | Probiotic bacteria containing oral dosage form |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0709162.2A GB0709162D0 (en) | 2007-05-11 | 2007-05-11 | Dosage foam |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0709162D0 true GB0709162D0 (en) | 2007-06-20 |
Family
ID=38219301
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0709162.2A Ceased GB0709162D0 (en) | 2007-05-11 | 2007-05-11 | Dosage foam |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2155218A1 (en) |
GB (1) | GB0709162D0 (en) |
WO (1) | WO2008138571A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8444967B2 (en) | 2010-07-09 | 2013-05-21 | Master Supplements, Inc. | Treatment including prebiotic composition for use with probiotics |
US20120015075A1 (en) * | 2010-07-13 | 2012-01-19 | Hero Nutritionals, LLC | Chewable supplement with live microorganisms |
BR112020021204A2 (en) * | 2018-04-18 | 2021-01-19 | Danstar Ferment Ag | COMPOSITION, METHOD TO RELIEVE OR SUPPRESS SYMPTOMS, METHOD OF FORMULATING A COMPOSITION TO RELIEVE OR SUPPRESS SYMPTOMS, USE OF A COMPOSITION AND NON-THERAPEUTIC USE OF AT LEAST ONE BACTERIAL BODY |
KR20230057906A (en) * | 2021-10-22 | 2023-05-02 | 그레이프 킹 바이오 리미티드 | Oral composition for reducing tobacco addiction |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE501640T1 (en) * | 1998-08-12 | 2011-04-15 | Nestle Sa | INCORPORATION OF EXOGENEOUS LACTIC ACID BACTERIA INTO THE MICROFLORA |
ES2708552T3 (en) * | 2002-12-20 | 2019-04-10 | Niconovum Ab | Method for the preparation of a particulate material containing nicotine with a crystalline cellulose (in particular MCC) |
EP1608314A2 (en) * | 2003-04-02 | 2005-12-28 | Pharmachem Laboratories, Inc. | Novel probiotic compositions and methods of using the same |
AU2004266615B2 (en) * | 2003-08-11 | 2008-07-17 | ProBiora Health, LLC | Compositions and methods for the maintenance of oral health |
WO2006000233A1 (en) * | 2004-06-29 | 2006-01-05 | Fertin Pharma A/S | Tobacco alkaloid containing chewing gum |
-
2007
- 2007-05-11 GB GBGB0709162.2A patent/GB0709162D0/en not_active Ceased
-
2008
- 2008-05-09 WO PCT/EP2008/003777 patent/WO2008138571A1/en active Application Filing
- 2008-05-09 EP EP08758453A patent/EP2155218A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP2155218A1 (en) | 2010-02-24 |
WO2008138571A1 (en) | 2008-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0700580D0 (en) | Use | |
GB0712503D0 (en) | Use | |
GB0714670D0 (en) | Use | |
AU318442S (en) | Footbath | |
HK1137363A1 (en) | Novel dosage form | |
GB0721332D0 (en) | Medicaments | |
GB0719518D0 (en) | Therapy | |
GB0708777D0 (en) | Dispensers | |
IL183496A0 (en) | Single use sinkstainer | |
GB0709162D0 (en) | Dosage foam | |
GB0702498D0 (en) | Foam | |
EP2114208A4 (en) | Chair | |
PL2140087T3 (en) | Fitting | |
GB0724236D0 (en) | Pharmaceutical foams | |
GB2452280B (en) | Lounger | |
GB0717450D0 (en) | Medicament | |
GB0721333D0 (en) | Medicaments | |
GB0808690D0 (en) | Therapeutic use | |
EP2159685A4 (en) | Processor | |
GB0701096D0 (en) | Use | |
GB0716072D0 (en) | Therapy | |
GB0700635D0 (en) | Therapy | |
GB0704123D0 (en) | Dosage form | |
AU3577P (en) | Valmic Stromanthe sanguinea | |
GB0723431D0 (en) | Foaming body-wash |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |